This is a routine odd-lot buy-back with negligible financial effect. Monitor for any subsequent announcements regarding clinical pipeline or capital raises, as this filing has no trading catalyst.
Price Chart
Executive Summary
Immuron Ltd filed a Form 6-K with the SEC to report the cancellation of 3,805,528 ordinary shares via a buy-back of unmarketable parcels on the ASX, at AUD 0.032 per share. The buy-back is a routine capital management action to eliminate small odd-lot holdings and has no material impact on the company's financial position or operations.
Key Facts
- Immuron cancelled 3,805,528 ordinary shares on June 29, 2026 via buy-back of unmarketable parcels.
- Consideration paid was AUD 0.032 per share.
- Post-cancellation, total quoted shares on ASX are 322,848,081.
- Unquoted securities: 3,767,492 performance rights and 8,000,000 options remain outstanding.
Financial Impact
AUD 121,776.90 total consideration paid for the buy-back (3,805,528 shares × AUD 0.032). No material financial impact on a company with a $7M market cap.
Risk Factors
- Further share price weakness could trigger additional unmarketable parcel buy-backs.
- No change to fundamental business outlook or cash runway.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-072858 |
| Document: ea0296227-6k_immuron.htm | 0001213900-26-072858 |
| Document: 0001213900-26-072858-index-headers.html | 0001213900-26-072858 |
| Document: 0001213900-26-072858-index.html | 0001213900-26-072858 |
| Document: 0001213900-26-072858.txt | 0001213900-26-072858 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $0.9300 | awaiting T+60 | — | $0.9200 (−1.08%) |
Oct 23, 2026 4d ago | 6-K | $0.9200 | awaiting T+60 | — | $0.9200 (+0.00%) |
Oct 23, 2026 4d ago | 424B5 | $0.9200 | awaiting T+60 | — | $0.9200 (+0.00%) |
Oct 21, 2026 6d ago | 6-K | $0.9490 | awaiting T+60 | — | $0.9200 (−3.06%) |
Oct 16, 2026 11d ago | 6-K | $0.9821 | awaiting T+60 | — | $0.9200 (−6.32%) |
Oct 13, 2026 14d ago | 6-K | $1.04 | awaiting T+60 | — | $0.9200 (−11.54%) |
Sep 24, 2026 4w ago | 20-F | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 24, 2026 4w ago | 6-K | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 21, 2026 5w ago | 6-K | $1.26 | awaiting T+60 | — | $0.9200 (−26.69%) |
Sep 4, 2026 7w ago | Press Release | $1.80 | awaiting T+60 | — | $0.9200 (−48.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers